Physician profile
Christopher R Leland
NPI 1871185769
$6,053.01
in general payments reported to CMS, 2019-2025
5 companies · $2,529 in 2025
The $2,529 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $80.57 · 2024: $3,443 · 2025: $2,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,500 · Food and Beverage: $1,508 · Travel and Lodging: $1,243 · Education: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,500.00 |
| Food and Beverage | $1,507.74 |
| Travel and Lodging | $1,242.79 |
| Education | $802.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,164.71 | 2023-2025 | Na, Actis, Stratafix |
| Stryker Corporation | $702.60 | 2024-2025 | T2 Alpha, Pangea, Triathlon |
| Zimmer Biomet Holdings, INC. | $87.56 | 2024 | Avitus Bone Harvester |
| Medtronic, INC. | $60.00 | 2024 | Cd Horizon Spinal System |
| Integra Lifesciences Corporation | $38.14 | 2025 | Integra, Omnigraft, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Leland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.